238 related articles for article (PubMed ID: 33927297)
21. Serum and bal beta-D-glucan for the diagnosis of Pneumocystis pneumonia in HIV positive patients.
Salerno D; Mushatt D; Myers L; Zhuang Y; de la Rua N; Calderon EJ; Welsh DA
Respir Med; 2014 Nov; 108(11):1688-95. PubMed ID: 25448310
[TBL] [Abstract][Full Text] [Related]
22. Serum indicators for the diagnosis of pneumocystis pneumonia.
Tasaka S; Hasegawa N; Kobayashi S; Yamada W; Nishimura T; Takeuchi T; Ishizaka A
Chest; 2007 Apr; 131(4):1173-80. PubMed ID: 17426225
[TBL] [Abstract][Full Text] [Related]
23. Outcome of Pneumocystis jirovecii pneumonia diagnosed by polymerase chain reaction in patients without human immunodeficiency virus infection.
Hardak E; Neuberger A; Yigla M; Berger G; Finkelstein R; Sprecher H; Oren I
Respirology; 2012 May; 17(4):681-6. PubMed ID: 22390188
[TBL] [Abstract][Full Text] [Related]
24. Clinical utility of serum beta-D-glucan and KL-6 levels in Pneumocystis jirovecii pneumonia.
Nakamura H; Tateyama M; Tasato D; Haranaga S; Yara S; Higa F; Ohtsuki Y; Fujita J
Intern Med; 2009; 48(4):195-202. PubMed ID: 19218768
[TBL] [Abstract][Full Text] [Related]
25. [Investigation of Pneumocystis jirovecii pneumonia and colonization in iatrogenically immunosuppressed and immunocompetent patients].
Özkoç S; Bayram Delibaş S
Mikrobiyol Bul; 2015 Apr; 49(2):221-30. PubMed ID: 26167822
[TBL] [Abstract][Full Text] [Related]
26. Clinical evaluation of a (1,3)-beta-D-glucan assay for presumptive diagnosis of Pneumocystis jiroveci pneumonia in immunocompromised patients.
Del Bono V; Mularoni A; Furfaro E; Delfino E; Rosasco L; Miletich F; Viscoli C
Clin Vaccine Immunol; 2009 Oct; 16(10):1524-6. PubMed ID: 19692624
[TBL] [Abstract][Full Text] [Related]
27. Ability of quantitative PCR to discriminate
Perret T; Kritikos A; Hauser PM; Guiver M; Coste AT; Jaton K; Lamoth F
J Med Microbiol; 2020 May; 69(5):705-711. PubMed ID: 32369002
[No Abstract] [Full Text] [Related]
28. [Investigation of Pneumocystis jirovecii Infection and Colonization in Immunocompromised Patients with Pneumonia].
Gülbudak H; Öztürk C; Kuyugöz S; Tezcan Ülger S
Mikrobiyol Bul; 2020 Oct; 54(4):583-595. PubMed ID: 33107287
[TBL] [Abstract][Full Text] [Related]
29. Accuracy of Pneumocystis jirovecii Plasma Cell-Free DNA PCR for Noninvasive Diagnosis of Pneumocystis Pneumonia.
Moreno A; Epstein D; Budvytiene I; Banaei N
J Clin Microbiol; 2022 May; 60(5):e0010122. PubMed ID: 35387472
[TBL] [Abstract][Full Text] [Related]
30. [Investigation of Pneumocystis jirovecii in clinical specimens by different methods].
Tekinşen FF; Koç AN
Mikrobiyol Bul; 2013 Oct; 47(4):658-67. PubMed ID: 24237434
[TBL] [Abstract][Full Text] [Related]
31. Semiquantitative Real-Time PCR to Distinguish Pneumocystis Pneumonia from Colonization in a Heterogeneous Population of HIV-Negative Immunocompromised Patients.
Grønseth S; Rogne T; Hannula R; Åsvold BO; Afset JE; Damås JK
Microbiol Spectr; 2021 Sep; 9(1):e0002621. PubMed ID: 34346746
[TBL] [Abstract][Full Text] [Related]
32. Polymerase chain reaction-based detection of Pneumocystis jirovecii in bronchoalveolar lavage fluid for the diagnosis of pneumocystis pneumonia.
Oren I; Hardak E; Finkelstein R; Yigla M; Sprecher H
Am J Med Sci; 2011 Sep; 342(3):182-5. PubMed ID: 21642823
[TBL] [Abstract][Full Text] [Related]
33. Low cut-off value of serum (1,3)-beta-D-glucan for the diagnosis of Pneumocystis pneumonia in non-HIV patients: a retrospective cohort study.
Taniguchi J; Nakashima K; Matsui H; Watari T; Otsuki A; Ito H; Otsuka Y
BMC Infect Dis; 2021 Nov; 21(1):1200. PubMed ID: 34844554
[TBL] [Abstract][Full Text] [Related]
34. Effectiveness of a real-time PCR for diagnosis of Pneumocystis pneumonia in immunocompromised patients - Experience from a tertiary care center, India.
S D; S TD; Gupta R; Varughese S; Varghese GM; George B; Michael JS
J Mycol Med; 2022 May; 32(2):101241. PubMed ID: 34999296
[TBL] [Abstract][Full Text] [Related]
35. [The Pneumocystis jirovecii colonization in bronchoalveolar lavage (BAL) and bronchial washing and the comparison of methods which are used in diagnosis].
Özmen A; Mıstık R; Alver O; Coşkun F; Ursavaş A; Uzaslan E
Tuberk Toraks; 2013; 61(4):303-11. PubMed ID: 24506746
[TBL] [Abstract][Full Text] [Related]
36. Characteristics and clinical relevance of the quantitative touch-down major surface glycoprotein polymerase chain reaction in the diagnosis of Pneumocystis pneumonia.
Chumpitazi BF; Flori P; Kern JB; Brenier-Pinchart MP; Hincky-Vitrat V; Brion JP; Thiebaut-Bertrand A; Minet C; Maubon D; Pelloux H
Med Mycol; 2011 Oct; 49(7):704-13. PubMed ID: 21417683
[TBL] [Abstract][Full Text] [Related]
37. Screening Pneumocystis carinii pneumonia in non-HIV-infected immunocompromised patients using polymerase chain reaction.
Jiancheng W; Minjun H; Yi-jun A; Lan S; Zengzhu G; Jianrong S; Xixiong K
Diagn Microbiol Infect Dis; 2009 Aug; 64(4):396-401. PubMed ID: 19631093
[TBL] [Abstract][Full Text] [Related]
38. Detection of Pneumocystis jirovecii by Quantitative PCR To Differentiate Colonization and Pneumonia in Immunocompromised HIV-Positive and HIV-Negative Patients.
Fauchier T; Hasseine L; Gari-Toussaint M; Casanova V; Marty PM; Pomares C
J Clin Microbiol; 2016 Jun; 54(6):1487-1495. PubMed ID: 27008872
[TBL] [Abstract][Full Text] [Related]
39. Clinical Performance of (1,3) Beta-D Glucan for the Diagnosis of Pneumocystis Pneumonia (PCP) in Cancer Patients Tested With PCP Polymerase Chain Reaction.
Morjaria S; Frame J; Franco-Garcia A; Geyer A; Kamboj M; Babady NE
Clin Infect Dis; 2019 Sep; 69(8):1303-1309. PubMed ID: 30561560
[TBL] [Abstract][Full Text] [Related]
40. Recent Advances in the Diagnosis of Pneumocystis Pneumonia.
Song Y; Ren Y; Wang X; Li R
Med Mycol J; 2016; 57(4):E111-E116. PubMed ID: 27904052
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
